132 related articles for article (PubMed ID: 22210292)
1. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases.
Sanjary Pour M; Fallah S; Rabbani Chadegani A
Arch Gynecol Obstet; 2013 May; 287(5):1031-7. PubMed ID: 23224727
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
El-Haggar SM; Mostafa TM
Endocrine; 2015 Aug; 49(3):820-7. PubMed ID: 25539793
[TBL] [Abstract][Full Text] [Related]
4. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
6. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
7. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
9. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
11. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Tuppurainen M; Klimscheffskij R; Venhola M; Dieben TO
Contraception; 2004 May; 69(5):389-94. PubMed ID: 15105061
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
13. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
Larsson-Cohn U; Wallentin L; Zador G
Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Ishak R; Loh Chooi Khim
Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
Young RL; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile in women over 35 years old using triphasic combined oral contraceptives.
Aldrighi JM; Petta CA; Bahamondes L; Caetano ME; Martinez TR; De Lima GR
Contraception; 2004 May; 69(5):395-9. PubMed ID: 15105062
[TBL] [Abstract][Full Text] [Related]
18. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
[TBL] [Abstract][Full Text] [Related]
19. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
20. Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
Odabaşi AR; Küçük M; Yüksel H; Güner Z; Sezer SD
Gynecol Endocrinol; 2011 Mar; 27(3):176-9. PubMed ID: 20504105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
